Objectives: To synthesize new transitional metal complexes derived from 3-aryl-azo-4-hydroxy coumarin analogues and to evaluate their antimicrobial activities.
Objectives: To synthesize new transitional metal complexes derived from 3-aryl-azo-4-hydroxy coumarin analogues and to evaluate their antimicrobial activities.
Methods:
The syntheses of complexes of coumarin analogues were accomplished by mixing a hydro-alcoholic solution of 3-aryl-azo-4-hydroxy coumarin analogues with transition metal chlorides. The structural environment of the synthesized molecules was characterized using different instrumental methods. The antimicrobial activity of the compounds was determined by the agar well diffusion method.
Results: The cobalt complexes of (E)-3-((4-chlorophenyl) diazenyl)-4-hydroxy-2H-chromen-2-one (HL 1 ): (4a) and (E)-3-((4-methoxyphenyl) diazenyl)-4-hydroxy-2H-chromen-2-one (HL 2 ): (4e) showed excellent antimicrobial activities compared with their ligands.
Conclusion:
The reports of the antimicrobial investigation showed that the cobalt complexes of 3-aryl-azo-4-hydroxy coumarin analogues exhibited potential antimicrobial activity that was stronger than that of their ligands.
Introduction
Due to the increasing number of multi-drug-resistant microbial pathogens and the inclusion of emerging infectious diseases such as severe acute respiratory syndrome and avian influenza, the treatment of microbial infections still remains a challenging job with the available antimicrobials and remains a worldwide problem for clinical management. 12 activities. A literature survey also revealed that azo-bearing ligands have a modified therapeutic effect when combined with transition metal ions. 13, 14 The complexes of transition metals have significant biological functions including antibacterial, antifungal and anticancer activities. 15 Cobalt, copper, nickel and zinc are the potentially used metal ions that form low-molecular-weight complexes, which are found to be effective against various diseases. Literature support even suggests that metal complexes are more active than their ligands because the metal complexes serve as a vehicle for activation of the ligands as principal cytotoxic species. 16, 17 The biological aspects of metallic ligands depend upon the ease of cleaving the bond between the metal ion and the ligand. It is well known that the metals present in complexes generally accelerate the drug action and the efficacy of therapeutic agents and that the pharmacological efficiencies of drug-based metal complexes depend upon the nature of the metal ion and the ligands. 18 The present work is the continuation of our previously reported work to obtain some novel complexes where the 4-chlorophenyl and 4-methoxyphenyl substituted 4-hydroxycumarin azoanalogues are conjugated with different transitional metals with an intention to produce target molecules possessing good antimicrobial properties.
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Materials and Methods
All the chemicals used in the present studies were of synthetic grade and were obtained from Merck specialties Ltd. and HiMedia laboratories Pvt. Ltd, (Mumbai, India). The prepared products were analysed by FT/IR (JASCO FT/IR 4100 Spectrophotometer) using KBr pellets. An LC-MS column C 6 (150 mm Â 4.6 mm) with a 5 mm particle size (Shimadzu-Mass spectrophotometer) was used. The 1 H NMR spectra were recorded on a Bruker 1 H NMR 400 MHz using tetramethylsilane as an internal standard, and the chemical shifts were reported in d ppm. The UV (Jasco V-630 Spectrophotometer) and elemental analyses for C, H, N and S were performed on a Perkin Elmer model 2400 CHNS/O analyser. A Shimadzu XRD 7000 was used for the study of the structural environment of the synthesized ligands and their metal complexes. The Faraday balance technique was employed for the measurement of magnetic susceptibility of the metal complexes. The in vitro antimicrobial activities against different bacterial and fungal pathogens were determined by the agar well diffusion method, sourced from IMTECH, India, Chandigarh.
Synthesis of ligands (3ae3b)
The synthetic procedures yielding the ligands (E)-3-((4-chlorophenyl) diazenyl)-4-hydroxy-2H-chromen-2-one (HL 1 ): (3a) and (E)-3-((4-methoxyphenyl) diazenyl)-4-hydroxy-2H-chromen-2-one (HL 2 ): (3b) were carried out as described previously. 3 Synthesis procedure of metal complexes (4ae4h) 20 A mixture of 25 mL was prepared with the appropriate metal chloride (Cu(II), Ni(II), Co(II) and Zn(II) of 10 mmol in ethanol and water, 1:1). The above mixture was added to the solution of azo compound 3ae3b (0.40 g, 10 mmol) in ethanol and water in equal proportions to obtain 50 mL of solution. The resulting solution was refluxed for 30 min at a controlled temperature not more than 78 C. The precipitated complexes were separated by filtration using Whatman filter paper. Separated precipitates were washed with 1:1 ethanol-water. Finally, obtained products were recrystallized from diethyl ether and air dried.
Off yellow-coloured powder; yield 91%; Rf: 0.7; m.p.: 235e40 C; UVeVis (l max, DMSO): 409 nm; IR (KBr, n, 
Antimicrobial activity
The above newly synthesized 4-HC azo-analogues and their metal complexes were investigated over different freshly sub cultured microbial strains, viz. Escherichia coli (MTCC 614), Klebsiella pneumonia (MTCC 109) and Candida albicans (MTCC 3017), that were procured from the Institute of Microbial Technology and Gene bank (IMTECH), Chandigarh, India. Staphylococcus aureus and Cryptococcus neoformans were obtained from the University Department of Pharmaceutical Sciences, Utkal University. Ampicillin and fluconazole were used as reference antibiotics.
The antimicrobial diffusion test was performed using a cell suspension of approximately 1.5 Â 10 6 CFU mL 
Minimum inhibitory concentration (MIC)
A 1 mg mL À1 stock solution of each of the synthesized compounds and reference antibiotic was prepared using DMF. Further, five different concentrations (500e 31.25 mg mL À1 ) were prepared by the serial dilution method.
The different concentrations for the respective compounds were loaded into the wells and incubated at 37 C for 18e 24 h. After incubation, the MIC was determined. 420 (2000) for the acute oral toxicity fixed dose procedure of the test compounds (3ae3b and 4ae4h) was followed. To conduct the sighting study, a single animal was provided with suspensions of the synthesized compounds having a specific dose, viz. 5 mg, 50 mg, 300 mg and 2000 mg/kg body weight, with the aid of an intubation canula. A period of 24 h was maintained between each dosing. In the main study, another 4 animals were administered 2000 mg/kg. The animals were observed for a period of 14 days. However, the acute toxic symptoms and the behavioural changes produced by the test compounds were observed continuously at an interval of 4 h up to 24 h.
Statistical analysis
The observed data on the zone of inhibitions were subjected to a one way analysis of variance. The mean zone of inhibition for each compound on each strain was compared with the reference antibiotic through a Dunnett Post Hoc test (https://www.statstodo.com/SSizAOV_Pgm.php). The test of significance was performed at the 5% level of type one error. The research hypothesis was 'the zone of inhibition for the test compound was higher than the reference antibiotics' against the hypothesis of no difference (null hypotheses), which states that there is no significant difference between the zone of inhibition of the test compound and the reference antibiotics.
Sample size determination
A minimum sample size of five was calculated taking the probability of type 1 error (d) ¼ 0.05, Power (1-b) ¼ 0.8, Number of groups ¼ 13 within group SD ¼ 2. However, a sample size of six has been taken in the study for each compound against each strain.
Results
The metal complexes of 3-aryl-azo-4-hydroxy coumarin analogues were synthesized by refluxing different hydro alcoholic solutions of metal chlorides with 3-(4-chloro phenyl/4-methoxy phenyl)-azo-4-hydroxy coumarin analogues (Scheme 1) and finally re-crystallized from diethyl ether. The structures of the prepared compounds are confirmed by different instrumental methods of analysis. The physical characteristics of the synthesized compounds are reported in Table 1 Figure 2 ). All of the complexes showed signals at a range of (6.90e7.26)e(7.23e7.37) ppm corresponding to {m, 8H, (C 6 H 4 ) 2 }.
The magnetic susceptibility of the Co(II) complex is 5.09 BM, which is nearer to the reported value for octahedral symmetry. 21 The Ni(II) complex showed a magnetic moment of 2.94 BM, whereas the Cu(II) complex showed a magnetic moment of 1.98 BM, suggesting an octahedral geometry. Compounds 3ae3b act as bidentate ligands by coordinating to the transitional metal ions through their azo and enolic hydroxyl moiety. Based upon the study of magnetic susceptibility values of the complexes, the probable structure is given in Scheme 1.
The predicted molecular weights of the synthesized compounds were confirmed by LCeMS and the results are summarized in Table 1 . Compound 3a possesses a molecular ion peak at 301.2 m/z that strongly reveals the predicted molecular formula C 15 H 9 ClN 2 O 3 that is reported in Figure 4 .
The UV spectroscopic analyses of the synthesized ligands and complexes revealed that complexes 4a and 4e demonstrated a good bathochromic shift at 463 and 450 nm, whereas ligands 3a and 3b possessed a l max at 409 and 413 nm, respectively. The solvent effect of the ligands and their respective complexes are spectrally presented in Figure 3 .
The X-ray diffraction (XRD) technique provides the most definitive structural information. The study of the XRD pattern of the synthesized complexes was performed using a Cu Ka X-ray source and a step of 0.02 (2q) and run at 2q ¼ 2e80 using a Shimadzu XRD 7000 instrument at a scanning speed of 2.000 (deg/min). Using Origin data analysis software, the structures of the obtained complexes were interpreted. The pattern and the number of reflections reported in Figure 5 clearly declared the structural difference of compounds 4e and 4f.
The results of the antimicrobial activity of the newly synthesized 3-aryl-azo-4-hydroxy coumarin analogues and their complexes compared with reference antibiotics (RA) ampicillin and fluconazole (as antibacterial and antifungal standard drugs, respectively) expressed in mean AE SD are reported in Table 2 . The reported results revealed that compounds 4a and 4e showed significant antimicrobial activity in comparison to standard drugs (p < 0.05) against E. coli, K. pneumonia, S. aureus, C. albicans and C. neoformans. All compounds except for 4d and 4h showed significant antibacterial activity against S. aureus. However, complex 4a showed highest mean zone of inhibition (mm) against K. pneumonia and C. neoformans, 19 AE 1.1 and 27.5 AE 1.64, respectively. The largest mean zones of inhibition exhibited by complex 4e against S. aureus and C. neoformans was 23 AE 2.28 and 28.17 AE 1.72, respectively. The anti-biogram pattern of compound 3a, 3b and their complexes against different fungal strains are illustrated in Figure 6 . The graphical representation of complexes 4a and 4e is illustrated in Figure 7 .
The inhibitory property of the compounds was determined in terms of MIC (mg mL À1 ). The Co þþ complexes of both the ligands showed the antimicrobial activity against all the selected strains at MIC level 31.25 mg mL À1 . All compounds except for 4d and 4h showed a zone of inhibition at the MIC level 31.25 mg mL À1 against C. albicans (Table 3) .
No mortality was found for all of the test compounds per the results of the toxicity study. The synthesized compounds were safe up to 2000 mg/kg body weight. No significant change in the body weight of the animals was observed. No toxic symptoms and gross behavioural changes were observed in the animals.
Discussion
The FT/IR spectra of synthesized ligands 3a and 3b showed vibrations at 1619e1603 cm À1 , 1726e1745 cm À1 , 1298e1246 cm À1 and 1529e1505 cm À1 corresponding to C]C str., C]O str., CeO str. and N]N str., respectively, which were also observed in the synthesized complexes (4ae 4h). The only exception is the bands due to OH str. at 3479e 3445 cm À1 exhibited in the ligands that are not observable in the complexes. In metal Cu(II), Ni(II) Co(II) and Zn(II) complexes of 3a and 3b, the FT/IR absorption band due to the hydroxyl group at 4-HC has been diminished and indicates the metal co-ordination of the OH group via deprotonation due to liberation of hydrochloric acid. In addition to these FT/IR spectral data, stretching of the MÀN and MÀO bonds of the complexes, which appear in the higher frequency wavenumber region in the range 451e441 and 538e531 cm À1 , also indicates that complexation occurred through nitrogen and oxygen atoms from the azo-enolic ligands. 22, 23 The 1 H NMR spectra of ligands 3a and 3b showed the enolic OH peak at 16.81 and 16.86 ppm. The disappearance of the enolic OH group in all the complexes (4ae4h) may be due to the interaction of metal chlorides Scheme 1: Synthesis of coumarin based transitional metal complexes. 24 Thus, it facilitates the penetration of the novel synthesized complexes into the lipoid cell membrane of microorganisms and inhibits their growth. The limitations of our study include only the investigation of antimicrobial activity of the novel synthesized complexes against a few bacterial and fungal strains. Furthermore, it is necessary to investigate the antimicrobial activities of the novel complexes against multidrug-resistant microorganisms.
A literature survey revealed that the metal complexes serve as vehicles for activation of the ligands as principal cytotoxic species. Therefore, these complexes may be implemented for the investigation of cytotoxic activity against different cancer cell lines. 
